Francisco C. Miralles-Perez
Fernando Abril Martorell Avenue 106
Valencia, VC 46026, Spain
Valencia, VC 46026, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Stage-Specific Gene Expression Profiles in Multiple Sclerosis Cortical Lesions Identified via Spatial Transcriptomics.
Journal: Omics : a journal of integrative biology
Published: August 17, 2026
Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression.
Journal: Multiple sclerosis and related disorders
Published: May 14, 2026
Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0.
Journal: Multiple sclerosis and related disorders
Published: March 19, 2026
Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.
Journal: European journal of neurology
Published: August 31, 2025
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays.
Journal: Frontiers in neurology
Published: August 08, 2025
An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing.
Journal: Advances in laboratory medicine
Published: June 10, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
Journal: JAMA neurology
Published: June 02, 2025
Correction to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: December 31, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis.
Journal: Journal of neurology
Published: September 09, 2024
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels.
Journal: Frontiers in neurology
Published: August 07, 2024
Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report.
Journal: Frontiers in immunology
Published: July 21, 2024
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 24, 2024
Last Updated: 09/26/2026